Cargando…
Physical Inactivity in Pulmonary Sarcoidosis
PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520325/ https://www.ncbi.nlm.nih.gov/pubmed/30888492 http://dx.doi.org/10.1007/s00408-019-00215-6 |
_version_ | 1783418717568237568 |
---|---|
author | Cho, Peter S. P. Vasudevan, Sharmila Maddocks, Matthew Spinou, Arietta Chamberlain Mitchell, Sarah Wood, Claire Jolley, Caroline J. Birring, Surinder S. |
author_facet | Cho, Peter S. P. Vasudevan, Sharmila Maddocks, Matthew Spinou, Arietta Chamberlain Mitchell, Sarah Wood, Claire Jolley, Caroline J. Birring, Surinder S. |
author_sort | Cho, Peter S. P. |
collection | PubMed |
description | PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relationship with lung function, exercise capacity, symptom burden, and health status. METHODS: Physical activity was assessed over one week in 15 patients with pulmonary sarcoidosis and 14 age-matched healthy controls with a tri-axial accelerometer (ActivPal™) and the International Physical Activity Questionnaire (IPAQ). All participants underwent pulmonary function tests, 6-min walk test (6MWT) and completed the Fatigue Assessment Scale (FAS), Medical Research Council (MRC) Dyspnoea Scale and the King’s Sarcoidosis Questionnaire (KSQ). RESULTS: Patients with sarcoidosis had significantly lower daily step counts than healthy controls; mean (SD) 5624 (1875) versus 10,429 (2942) steps (p < 0.01) and a trend towards fewer sit-to-stand transitions each day (p = 0.095). Only two patients (13%) self-reported undertaking vigorous physical activity (IPAQ) compared to half of healthy individuals (p < 0.01). Daily step count was significantly associated with 6MWT distance in sarcoidosis (r = 0.634, p = 0.01), but not with forced vital capacity (r = 0.290), fatigue (r = 0.041), dyspnoea (r = −0.466) or KSQ health status (r = 0.099–0.484). Time spent upright was associated with fatigue (r = −0.630, p = 0.012) and health status (KSQ Lung scores r = 0.524, p = 0.045), and there was a significant correlation between the number of sit-to-stand transitions and MRC dyspnoea score (r = −0.527, p = 0.044). CONCLUSION: Physical activity is significantly reduced in sarcoidosis and is associated with reduced functional exercise capacity (6MWD). Fatigue, exertional symptoms and health status were more closely associated with time spent upright and the number of bouts of physical activity, as compared to step counts. Further studies are warranted to identify the factors that determine different physical activity profiles in sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00408-019-00215-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6520325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-65203252019-06-05 Physical Inactivity in Pulmonary Sarcoidosis Cho, Peter S. P. Vasudevan, Sharmila Maddocks, Matthew Spinou, Arietta Chamberlain Mitchell, Sarah Wood, Claire Jolley, Caroline J. Birring, Surinder S. Lung Interstitial Lung Disease PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relationship with lung function, exercise capacity, symptom burden, and health status. METHODS: Physical activity was assessed over one week in 15 patients with pulmonary sarcoidosis and 14 age-matched healthy controls with a tri-axial accelerometer (ActivPal™) and the International Physical Activity Questionnaire (IPAQ). All participants underwent pulmonary function tests, 6-min walk test (6MWT) and completed the Fatigue Assessment Scale (FAS), Medical Research Council (MRC) Dyspnoea Scale and the King’s Sarcoidosis Questionnaire (KSQ). RESULTS: Patients with sarcoidosis had significantly lower daily step counts than healthy controls; mean (SD) 5624 (1875) versus 10,429 (2942) steps (p < 0.01) and a trend towards fewer sit-to-stand transitions each day (p = 0.095). Only two patients (13%) self-reported undertaking vigorous physical activity (IPAQ) compared to half of healthy individuals (p < 0.01). Daily step count was significantly associated with 6MWT distance in sarcoidosis (r = 0.634, p = 0.01), but not with forced vital capacity (r = 0.290), fatigue (r = 0.041), dyspnoea (r = −0.466) or KSQ health status (r = 0.099–0.484). Time spent upright was associated with fatigue (r = −0.630, p = 0.012) and health status (KSQ Lung scores r = 0.524, p = 0.045), and there was a significant correlation between the number of sit-to-stand transitions and MRC dyspnoea score (r = −0.527, p = 0.044). CONCLUSION: Physical activity is significantly reduced in sarcoidosis and is associated with reduced functional exercise capacity (6MWD). Fatigue, exertional symptoms and health status were more closely associated with time spent upright and the number of bouts of physical activity, as compared to step counts. Further studies are warranted to identify the factors that determine different physical activity profiles in sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00408-019-00215-6) contains supplementary material, which is available to authorized users. Springer US 2019-03-19 2019 /pmc/articles/PMC6520325/ /pubmed/30888492 http://dx.doi.org/10.1007/s00408-019-00215-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Interstitial Lung Disease Cho, Peter S. P. Vasudevan, Sharmila Maddocks, Matthew Spinou, Arietta Chamberlain Mitchell, Sarah Wood, Claire Jolley, Caroline J. Birring, Surinder S. Physical Inactivity in Pulmonary Sarcoidosis |
title | Physical Inactivity in Pulmonary Sarcoidosis |
title_full | Physical Inactivity in Pulmonary Sarcoidosis |
title_fullStr | Physical Inactivity in Pulmonary Sarcoidosis |
title_full_unstemmed | Physical Inactivity in Pulmonary Sarcoidosis |
title_short | Physical Inactivity in Pulmonary Sarcoidosis |
title_sort | physical inactivity in pulmonary sarcoidosis |
topic | Interstitial Lung Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520325/ https://www.ncbi.nlm.nih.gov/pubmed/30888492 http://dx.doi.org/10.1007/s00408-019-00215-6 |
work_keys_str_mv | AT chopetersp physicalinactivityinpulmonarysarcoidosis AT vasudevansharmila physicalinactivityinpulmonarysarcoidosis AT maddocksmatthew physicalinactivityinpulmonarysarcoidosis AT spinouarietta physicalinactivityinpulmonarysarcoidosis AT chamberlainmitchellsarah physicalinactivityinpulmonarysarcoidosis AT woodclaire physicalinactivityinpulmonarysarcoidosis AT jolleycarolinej physicalinactivityinpulmonarysarcoidosis AT birringsurinders physicalinactivityinpulmonarysarcoidosis |